Calendar

August 2017
SunMonTueWedThuFriSat
 << < > >>
  12345
6789101112
13141516171819
20212223242526
2728293031  

Announce

Who's Online?

Member: 0
Visitor: 1

rss Syndication

Archives

23 Aug 2012 
A news article by Bloomberg News reported that Johnson and Johnson, the maker of the DePuy ASR hip replacement, is one of five artificial hip and knee manufacturers to cut back on payouts to surgeons in exchange for exclusive use of their products. 

Instead of facing criminal charges, the five largest manufacturers, Johnson & Johnson’s DePuy unit, Zimmer Holdings Inc., Stryker Corporation, Smith & Nephew Plc and Biomet Inc., agreed to pay $311 million to settle the 2007 lawsuit that charged them with providing kickbacks. The companies also had to agree to disclose all their consulting agreements with doctors, put the payment amounts on their corporate Web sites and allow federal monitors to oversee their actions. 

According to the Archives of Internal Medicine, the following compensations were made: 
  • 2007 – $198 million paid out to 939 orthopaedic surgeons 
  • 2008 - $119 million paid to 568 surgeons, in addition to $109 million in royalty buyouts from Zimmer

Controversy surrounding the DePuy hip replacement lawsuit and other metal-on-metal hip replacement issues began shortly after it was discovered that the devices were failing at a faster rate than anticipated. 

Read More: Plaintiffs Lose DePuy ASR MDL Transfer Motion

Admin · 234 views · 0 comments
Categories: First category
21 Jun 2012 


It seems that patients all over
the world who have received the DePuy ASR hip replacements systems are having
problems with the device. In several other countries, the United Kingdom
especially, have reported that patients have been experiencing high failure
rates. 

 According the British Orthopaedic Association
and the British Hip Society the data on the ASR XL Acetabular System from four
surgeons show the rate of second operations, or revisions, ranges from 21
percent after four years to 49 percent after six years. According to John
Skinner, an orthopedic surgeon and chairman of the groups’ expert advisory
group on metal bearing hips, about 10,000 of the hips were implanted in the
U.K., including 5,000 or so resurfacing devices and 5,000 of the ASR XL prostheses,
also known as total-hip replacements. 


However, these numbers differ
from what DePuy has stated as the official failure rate for their products.
Information by DePuy was released that the official failure rate is 13 percent
of ASR XL patients required second surgeries in five years, and 12 percent of
patients with the resurfaced hips needed such operations within five years.
These numbers were enough for DePuy to officially recall the ASR and ASR XL
from the worldwide market. 

The Medicine and Healthcare
products Regulations Agency (MHRA), which is the UK version of the FDA, gave
notice that it has recommended that no further DePuy ASP hip replacements be
implanted, that all unused ASR hip replacement implants were to be returned to
the manufacturer and that all patients implanted with ASR hip replacements were
to be informed of the product recall and called in for check-ups. , gave notice
that it has recommended that no further DePuy ASP hip replacements be
implanted, that all unused ASR hip replacement implants were to be returned to
the manufacturer and that all patients implanted with ASR hip replacements were
to be informed of the product recall and called in for check-ups. |The he
Medicine and Healthcare products Regulations Agency (MHRA), or the British
equivalent to the FDA, has given notice that it has recommended that no further
DePuy ASP hip replacements be implanted, that all unused ASR hip replacement
implants were to be returned to the manufacturer and that all patients
implanted with ASR hip replacements were to be informed of the product recall
and called in for check-ups.

 If patients begin to show the following
symptoms they are advised to visit their doctor as soon as possible: anxiety,
cognitive decline. depression or memory loss.Other physical reactions could
include:  dizziness, fatigue, hearing
loss, tissue damage, tumors, tremors, nerve damage, ringing in ears, bone
damage, organ damage, and vision problems. 

Currently DePuy faces hundreds of
lawsuits which have been filed by patients who have suffered from their ASR
line of products. Many experts believe that DePuy may stand to loose over a
billion dollars due to legal actions.


URL References:

bbc.co.uk/news/health-17192520

bloomberg.com/news/2011-03-09/j-j-hip-replacement-failure-rate-may-be-49-u-k-orthopedists-group-says.html



Admin · 115 views · Leave a comment
Categories: First category